Florida 2021 Regular Session Status: In Committee

HB 3551 — Jordan Avi Ogman Foundation TECPR2 Research & Development of Gene Therapy Cure for Rare Neurodegenerative Disease

Last action — Vetoed by Governor; See SB 2500 (line item 468)

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2021 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Jordan Avi Ogman Foundation TECPR2 Research & Development of Gene Therapy Cure for Rare Neurodegenerative Disease; Provides an appropriation for the Jordan Avi Ogman Foundation TECPR2 Research & Development of Gene Therapy Cure for Rare Neurodegenerative Disease. APPROPRIATION: $50,000

Bill Text

Action History

  1. Vetoed by Governor; See SB 2500 (line item 468)

  2. See SB 2500 (line item 468)

  3. 1st Reading (Original Filed Version)

  4. Now in Health Care Appropriations Subcommittee

  5. Referred to Appropriations Committee

  6. Referred to Health Care Appropriations Subcommittee

  7. Filed

Sponsors

  • Slosberg · Primary

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 163 not signed on

Sponsors (1)

  • Slosberg

Co-sponsors (0)

None.

Not signed on (163)

163 members have not signed on to this bill.

Show all 163 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare technology
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 3551 do?
Jordan Avi Ogman Foundation TECPR2 Research & Development of Gene Therapy Cure for Rare Neurodegenerative Disease; Provides an appropriation for the Jordan Avi Ogman Foundation TECPR2 Research & Development of Gene Therapy Cure for Rare Neurodegenerative Disease. APPROPRIATION: $50,000
Who sponsors HB 3551?
HB 3551 is sponsored by Slosberg.
What is the current status of HB 3551?
This bill died with 2021 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 3551?
Track HB 3551 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 3551

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 3551

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →